Article info
Clinical and epidemiological research
Concise report
Efficacy and safety of long-term low molecular weight heparin in patients with antiphospholipid syndrome
- Correspondence to Munther A Khamashta, Lupus Research Unit, The Rayne Institute, 4th Floor Lambeth Wing, St Thomas‘ Hospital, London SE1 7EH, UK; munther.khamashta{at}kcl.ac.uk
Citation
Efficacy and safety of long-term low molecular weight heparin in patients with antiphospholipid syndrome
Publication history
- Accepted May 1, 2011
- First published May 30, 2011.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions